Martin Haswell is a seasoned professional in the pharmaceutical industry, currently serving as a Board Member for Legemiddelindustrien (LMI) since March 2022. Haswell has an extensive tenure at Roche, beginning in November 2003, where roles have included General Manager of Roche Pharma Norway, Head of Transformation in Global Product Strategy, and various leadership positions in immunology, haematology, and oncology. Prior experience includes a role as a Graduate Research Student at GlaxoSmithKline from 2001 to 2002. Martin Haswell holds an M.Sci in Medical Biochemistry from the University of Glasgow, completed in 2003.
This person is not in any teams
This person is not in any offices